Adicet Bio, Inc. (NASDAQ:ACET – Free Report) – Research analysts at Wedbush dropped their Q2 2024 EPS estimates for shares of Adicet Bio in a research report issued on Wednesday, May 15th. Wedbush analyst R. Driscoll now expects that the company will earn ($0.37) per share for the quarter, down from their previous forecast of […]
Adicet Bio, Inc. (NASDAQ:ACET – Free Report) – Investment analysts at Wedbush cut their Q2 2024 earnings per share estimates for Adicet Bio in a research note issued on Wednesday, May 15th. Wedbush analyst R. Driscoll now anticipates that the company will earn ($0.37) per share for the quarter, down from their previous estimate of […]
StockNews.com upgraded shares of Adicet Bio (NASDAQ:ACET – Free Report) to a sell rating in a research report sent to investors on Friday. ACET has been the subject of several other reports. Canaccord Genuity Group reaffirmed a buy rating and issued a $19.00 price target on shares of Adicet Bio in a research note on […]
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among […]
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) has earned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among […]